Vücut kitle endeksinin üreteroskopik pnömolitotripsi sonuçlarına etkisi

Abstract

Amaç: Vücut kitle indeksinin üreteroskopik pnömolitotripsi sonuç ve morbiditesini etkileyip etkilemediğini belirlemek. Gereç ve Yöntemler: Ocak 2006-Nisan 2010 tarihleri arasında, 8 mm ile 15 mm boyutları arasındaki üreter taşı sebebiyle semirigid üreteroskopi URS eşliğinde pnömolitotripsi uygulanan 332 hasta çalışmaya dahil edildi.Hastalar vücut kitle endeksine BMI göre 4 gruba ayrıldı; Grup 1 normal , BMI 35 kg/m2. Hastalar preoperatif ve postoperatif düz karın grafisi, renal ultrasonografi, intravenöz piyelografi ve/veya kontrastsız spiral bilgisayarlı tomografi BT ile takip edildi. Tedavi edilen hastalarda 0.05 . Gruplar arasında taşsızlık oranları, komplikasyon oranları, operasyon süreleri ve hastanede kalış süreleri açısından farklılık izlenmedi.Sonuç: Çalışmamızda vücut-kitle endeksinin, üreteroskopi etkinliğine ve komplikasyon oranlarına etkisi gözlenmemiştir

Keywords

• Üreter taşı, üreter, vücut kitle indeksi

Impact of body mass index on success rates of ureteroscopic pneumolithotripsy

Abstract

Objective: To determine whether the body mass index BMI affects the outcome and morbidity of ureteroscopic pneumolitotripsy.Materials and Methods: From January 2006 to April 2010, 332 patients with ureteral stones ranging 8 mm to 15 mm, who underwent semirigid ureteroscopy URS with pneumolithotripsy, were included in the study. Patients were divided into four groups depending on their BMIs: ideal body weight

Keywords

• Body mass index,ureteral stone,ureteroscopy

References

1. Calle EE, Thun MJ, Petrelli JM, et al. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341:1097-1105.
2. Andreoni C, Afane J, Olweny E, et al. Flexible ureteroscopic lithotripsy: First line therapy for proximal ureteral and re- nal calculi in the morbidly obese and superobese patient. J Endourol 2001;15:493-8.
3. Pearle MS, Nakada SY, Womack JS, et al. Outcomes of con- temporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol 1998;160:669-73.
4. Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int 2003;63:1951-2.
5. Curhan GC. Epidemiology of stone disease. Urol Clin North Am 2007;34:287-93.
6. Bagrodia A, Gupta A, Raman JD, et al. Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy. Urology 2008; 72:756-60.
7. Delakas D, Karyotis I, Daskalopoulos G, et al. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endo- urol 2003;17:201-5.
8. Muñoz RD, Tirolien PP, Belhamou S, et al. Treatment of reno-ureteral lithiasis with ESWL in obese patients. Apro- pos of 150 patients. Arch Esp Urol 2003; 56: 933-8.

9. El-Nahas AR, El-Tabey NA, Eraky I, et al. Semirigid urete- roscopy for ureteral stones: a multivariate analysis of unfa- vorable results. J Urol 2009; 181: 1158-62.
10. Aslan Y, Kırılmaz U, Tuncel A, et al. Üreter taşı olan hasta- larda rigit üreteroskopi ve pnömotik litotripsi sonuçlarımız. Türk Üroloji Dergisi 2010;36:263-9.
11. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the as- sociation between body-mass index and mortality. N Engl J Med 1998;338: 1-7.
12. Türk C, Knoll T, Petrik A, et al. Guideline on urolithiasis, 2010: 1-106. Available at: http://www.uroweb.org/gls/pdf/ Urolithiasis%202010.pdf
13. Tomaszewski JJ, Smaldone MC, Schuster T, et al. Outcomes of percutaneous nephrolithotomy stratified by body mass index. J Endourol 2010:24:547-50.
14. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005:293:455-62.
15. Duffey BG, Pedro RN, Kriedberg C, et al. Lithoge- nic risk factors in the morbidly obese population. J Urol 2008;179:1401-6.
16. Calvert RC, Burgess NA. Urolithiasis and obesity: metabolic and technical considerations. Curr Opin Urol 2005;15:113-7.
17. Michel MS, Trojan L, Rassweiler JJ. Complications in percu- taneous nephrolithotomy. Eur Urol 2007;51:899-906.
18. Juan YS, Shen JT, Li CC, et al. Comparison of percutaneous nephrolithotomy and ureteroscopic lithotripsy in the mana- gement of impacted, large, proximal ureteral stones. Kaoh- siung J Med Sci 2008;24:204-9.
19. Natalin R, Xavier K, Okeke Z, et al. Impact of obesity on ureteroscopic laser lithotripsy of urinary tract calculi. Int Braz J Urol 2009;35:36-42.
20. Faerber GJ, Goh M. Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol 1997;3:89-95.
21. Tefekli A, Kurtoglu H, Tepeler K, et al. Does the metabolic syndrome or its components affect the outcome of percuta- neous nephrolithotomy? J Endourol 2008;22:35-40.
22. Schuster TG, Hollenbeck BK, Faerber GJ, et al. Complica- tions of ureteroscopy: analysis of predictive factors. J Urol 2001:166:538-40.
23. Johnson DB, Pearle MS. Complications of ureteroscopy. Urol Clin North Am 2004;31:157-71.
24. Best SL, Nakada SY. Flexible ureteroscopy is effective for proximal ureteral stones in both obese and nonobese pa- tients: a two-year, single-surgeon experience. Urology 2011;77:36-9.